Major Japanese multinational pharmaceutical companies succeeded in growth compared to the corresponding period last year

According to the prescription cost of eight major Japanese multinational pharmaceutical companies in the first half of 2013 based on the data of Ubist, five pharmaceutical companies succeeded in growth compared to the corresponding period last year. The total outpatient prescription drug sales in the first half was 144.7 billion won which increased by 8.6% compared to the previous year.

Astell...